Skin of Color: A Dermatology Guide

Skin of Color Overview

Skin of color encompasses diverse skin types with increased melanin production. Populations with skin of color (African, Hispanic, Asian, Middle Eastern descent) have unique dermatological considerations often inadequately addressed in dermatological training. Historically, dermatological literature focused on lighter skin types; skin of color conditions underrepresented in literature and research. This disparity results in delayed diagnoses, inappropriate treatments, and poor health outcomes. Culturally competent, evidence-based dermatology addressing skin of color unique needs is imperative.

Physiological Differences

Skin of color contains more densely packed, larger, and more numerous melanosomes. Melanin distributes throughout epidermis rather than concentrating in basal layer (lighter skin). This distribution provides superior natural UV protection (inherent SPF 13-16 vs 3-4 for light skin). However, this same increased melanin predisposes to post-inflammatory hyperpigmentation (PIH) following any inflammation. Transepidermal water loss (TEWL) higher in skin of color despite better barrier function, predisposing to dryness. Hair structure differences (curly, coily) create unique conditions (pseudofolliculitis barbae, traction alopecia).

Common Conditions

Pseudofolliculitis Barbae (PFB): Ingrown hair condition affecting men of color with curly hair. Hair shaft curves and re-enters dermis causing inflammation. Traction Alopecia: Hair loss from chronic pulling tension (tight braids, extensions, weaves). Preventable through styling modifications. Central Centrifugal Cicatricial Alopecia (CCCA): Scarring alopecia affecting women of African descent; progressive vertex alopecia. Early intervention prevents permanent hair loss. Acanthosis Nigricans: Dark velvety patches (neck, armpits, groin) associated with insulin resistance. More visible in dark skin. Lichen Planus Pigmentosus: Inflammatory condition causing hyperpigmentation, particularly in dark skin populations.

Hyperpigmentation

Post-inflammatory hyperpigmentation (PIH) occurs following any inflammatory insult (acne, folliculitis, eczema, laser treatment). Melanosome transfer to keratinocytes causes excess melanin deposition. PIH is primary complication of many dermatological procedures in skin of color. Prevention critical: gentle skincare, minimizing inflammation, sun protection, appropriate treatment selection. Treatment options: hydroquinone (first-line), tretinoin (adjunctive), combination regimens accelerate improvement. Azelaic acid beneficial. Chemical peels carefully selected (avoid deep peels). Laser treatment risky; non-ablative longer-wavelength options (Nd:YAG) preferable to ablative options or shorter wavelengths.

Keloids and Hypertrophic Scars

Keloids are excessive collagen deposition extending beyond original wound; predisposition genetic, affecting 5-15% of African descendants vs 1% of European descent. Hypertrophic scars confined to original wound; resolve more readily. Risk factors: ear piercings, minor trauma, chest/shoulder locations, age 10-30. Prevention through minimizing unnecessary procedures and careful surgical technique. Treatment: topical/intralesional corticosteroids (first-line), silicone products, pressure garments, cryotherapy, laser (PDL), surgical revision with post-operative silicone/steroids. Complete eradication difficult; recurrence common.

Treatment Modifications

Retinoids: Often well-tolerated; start lower concentrations (0.025% tretinoin) and titrate up. Post-inflammatory hyperpigmentation risk; monitor closely. Exfoliating Acids: Chemical peels require careful approach; superficial peels safer than medium/deep peels. Use gentler agents (lactic acid preferable to glycolic acid). Post-peel hydroquinone use prevents PIH. Antibiotics: Systemic antibiotics safe; topical options need careful selection for rosacea (azelaic acid preferable to other agents for dark skin).

Laser Treatment Considerations

Wavelength selection critical: longer wavelengths (Nd:YAG 1064nm) preferable to shorter wavelengths to avoid melanin absorption in epidermis. Avoid ablative lasers (CO2, erbium) due to scarring/dyspigmentation risk. Pulsed dye laser for vascular lesions safe. IPL use cautious; risk of PIH. Test patches essential to assess individual skin response before full treatment. Lower fluences than light skin protocols. More conservative approach advised throughout. Dark skin melanoma appears different (acral distribution, nail involvement more common); clinical suspicion maintained.

Skincare for Dark Skin

Barrier health paramount due to increased TEWL: frequent use of emollients essential. Fragrance-free products recommended; fragrance increases irritation risk and subsequent PIH. Gentle cleansing crucial to prevent irritation-triggered pigmentation changes. Sun protection critical despite higher inherent SPF; UV exposure causes unwanted pigmentation. Broad-spectrum SPF 30+ daily. Vitamin C serums support brightening; use stable formulations. Niacinamide beneficial for barrier repair and anti-inflammatory effects. Exfoliating acids cautiously; shorter contact times, lower frequencies. Hydroquinone for hyperpigmentation management effective and safe for dark skin in appropriate concentrations (2-4%).

Health Equity Considerations

Racial disparities in dermatology care exist through multiple mechanisms: inadequate representation in dermatological literature (skin of color conditions underrepresented), implicit bias affecting clinical care, limited research inclusion of diverse populations, lower melanoma awareness in dark-skin populations leading to later-stage diagnosis and worse outcomes. Improving health equity requires: expanding dermatology education on skin of color conditions, diversifying dermatology workforce and research, culturally competent patient education, and addressing systemic barriers to care. Individual dermatologists must commit to cultural competency and evidence-based care for all patients regardless of skin color.